ArticleCancer reports (Hoboken, N.J.)2024

JAK Inhibitor Upadacitinib Induces Remission in Refractory Immune-Related Colitis Triggered by CTLA-4 and PD-1 Inhibitor Combination Therapy in Malignant Pleural Mesothelioma: A Case Report.

Masashi Kono et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.